基本信息 产品详情 公司简介 推荐产品
  • 首页
  • 个人中心
  • 委托采购
  • 采购清单
网站主页 化工产品目录 生物化工 抗体 CAPNS1抗体 CAPNS1抗体
  • CAPNS1抗体
  • CAPNS1抗体

1/2

CAPNS1抗体

Rabbit Polyclonal CAPNS1 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期：2025-05-12

湖北瑞和宁生物科技有限公司

VIP1年
联系人：周经理
电话：027-19371278702拨打
手机：18008634902 拨打
邮箱：19384116026@163.com

产品详情:

中文名称：
CAPNS1抗体
英文名称：
Rabbit Polyclonal CAPNS1 Antibody
品牌：
艾普蒂
产地：
武汉
保存条件：
Stored at -20°C for 3395 year. Avoid repeated freeze / thaw cycles.
产品类别：
抗体
重组：
否
应用：
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性：
Human,Mouse,Rat
宿主：
Rabbit
偶联物：
无
靶点：
CAPNS1

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/1000-1/5000 Human,Mouse,Rat
   

产品详情

Aliases30K, CANP, CDPS, CSS1, CANPS, CAPN4, CALPAIN4
WB Predicted band size28 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenFusion protein of human CAPNS1
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 12%SDS-PAGE, Lysate: 60 μg, Lane 1-2: K562 cells, NIH/3T3 cells, Primary antibody: P07142(CAPNS1 Antibody) at dilution 1/800, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 15 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human ovarian cancer tissue using P07142(CAPNS1 Antibody) at dilution 1/60. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human brain tissue using P07142(CAPNS1 Antibody) at dilution 1/60. (Original magnification: ×200)    


           

参考文献

以下是关于CAPNS1抗体的3篇参考文献示例(文献信息为模拟概括，仅供参考)：

---

1. **文献名称**：*CAPNS1 regulates autophagy via modulating calcium-dependent calpain activation in neurodegenerative models*

**作者**：Li, X., et al.

**摘要**：本研究利用CAPNS1特异性抗体，验证了CAPNS1通过调控钙蛋白酶活性影响自噬通路，揭示了其在阿尔茨海默病模型中神经元退行性变的作用机制。

---

2. **文献名称**：*Targeting CAPNS1 as a therapeutic strategy in triple-negative breast cancer*

**作者**：Chen, Y., et al.

**摘要**：通过CAPNS1抗体检测发现，CAPNS1在三阴性乳腺癌中高表达，敲低CAPNS1可抑制肿瘤细胞迁移和侵袭，提示其作为潜在治疗靶点。

---

3. **文献名称**：*CAPNS1 deficiency disrupts skeletal muscle development via impaired calpain signaling*

**作者**：Smith, J.R., et al.

**摘要**：利用CAPNS1敲除小鼠模型及抗体进行蛋白互作分析，证实CAPNS1缺失导致钙蛋白酶活性丧失，进而影响肌肉分化相关蛋白的剪切和功能。

---

**注**：以上文献为示例性内容，实际引用时需以真实发表的论文为准。建议通过PubMed或Web of Science以“CAPNS1 antibody”或“calpain small subunit 1”为关键词检索最新研究。

       

背景信息

The CAPNS1 antibody targets the regulatory subunit of the calpain system, a family of calcium-dependent cysteine proteases. CAPNS1 (also known as calpain small subunit 1) is essential for stabilizing and activating calpain heterodimers, which consist of a catalytic large subunit (e.g., CAPN1/CAPN2) and CAPNS1. Calpains play critical roles in calcium-mediated signaling pathways, influencing processes such as cell migration, apoptosis, cytoskeletal remodeling, and membrane repair. Dysregulation of calpain activity is linked to pathologies including cancer metastasis, neurodegenerative diseases, and muscular dystrophy.

CAPNS1 antibodies are widely used to study calpain expression, localization, and function in diverse biological contexts. These antibodies enable detection of CAPNS1 via techniques like Western blotting, immunohistochemistry, and immunofluorescence. Researchers also employ CAPNS1 antibodies to investigate calpain complex formation, activity regulation, and interactions with substrates or inhibitors. In disease models, CAPNS1 antibodies help elucidate calpain's role in tissue injury, inflammation, or tumor progression. Additionally, they serve as tools for validating genetic knockdown/knockout models or assessing therapeutic interventions targeting calpain pathways. High specificity and sensitivity are critical for these applications, given the ubiquitous expression of calpains and their tight regulation in cells.

       


CAPNS1抗体;CAPNS1;CAPNS1 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力， 拥有完整、科学、质量管理体系。并不断致力于技术创新，产品创新和管理创新，赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ￥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

CAPNS1抗体相关厂家报价

内容声明
official 进入官方账号
拨打电话 立即询价